Cambridge University receives first synthesized DNA from Evonetix
Transfer marks start of vital development stage as company expands its range of synthesized DNA
Read More
Tag: DNA
Touchlight receives funding to develeop DNA vaccine platform
Bill & Melinda Gates Foundation grant will boost potential of nanoparticle-formulated doggybone DNA
Read More
‘Junk’ DNA may hold the key to neurological disorders
University of Lincoln and the University of Sheffield are researching how DNA could be repaired
Read More
Evonetix commences access programme for synthesised DNA
Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform
Read More
Scientists to rewrite DNA in search for heart disease cure
The British Heart Foundation’s ‘Big Beat Challenge’ grant of £30m for research into cardiovascular medicine was given to CureHeart
Read More
DNA analysis uncovers new cancer treatment clues
Researchers were able to detect specific combinations of genetic alterations which may hold key to the growth of cancers
Read More
Patent granted for Evonetix’s thermally-controlled DNA synthesis
In contrast to conventional methods, Evonetix uses thermal control which offers greater accuracy and selectivity
Read More
Scientists identify link between genetic changes and rare childhood cancer rhabdomyosarcoma
Genetic changes could be used to guide treatment for the rare and aggressive cancer type
Read More
Researchers develop highly sensitive blood test for cancer
Researchers have developed a new way of analysing cancer patients’ blood for evidence of the disease that could be up to ten times more sensitive than previous methods.
Read More
EXCLUSIVE: Brits back sharing DNA for research
The main reason for not sharing DNA for drug research is the fear it could be used without knowledge for corporate gain
Read More
Cell mechanism that repairs potentially cancerous DNA damage discovered
Researchers have discovered a cell mechanism that repairs potentially cancerous DNA damage.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
